These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 37976011

  • 1. Comparison of the Effect of Dialectical Behavior Therapy, Acceptance and Commitment Therapy mindfulness-based Stress Reduction on Irritable Bowel Syndrome Symptoms, Quality of Life, Anxiety and Depression: A Pilot Randomized Controlled Trial.
    Taghvaeinia A, Karami M, Azizi A.
    Psychiatr Q; 2024 Mar; 95(1):53-68. PubMed ID: 37976011
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial.
    Mohamadi J, Ghazanfari F, Drikvand FM.
    Psychiatr Q; 2019 Sep; 90(3):565-578. PubMed ID: 31152288
    [Abstract] [Full Text] [Related]

  • 3. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial.
    Zernicke KA, Campbell TS, Blustein PK, Fung TS, Johnson JA, Bacon SL, Carlson LE.
    Int J Behav Med; 2013 Sep; 20(3):385-96. PubMed ID: 22618308
    [Abstract] [Full Text] [Related]

  • 4. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life.
    Kearney DJ, McDermott K, Martinez M, Simpson TL.
    Aliment Pharmacol Ther; 2011 Aug; 34(3):363-73. PubMed ID: 21651595
    [Abstract] [Full Text] [Related]

  • 5. Reduced Symptoms of Post-Traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans.
    Harding K, Simpson T, Kearney DJ.
    J Altern Complement Med; 2018 Dec; 24(12):1159-1165. PubMed ID: 30160516
    [Abstract] [Full Text] [Related]

  • 6. Mindfulness-based stress reduction improves irritable bowel syndrome (IBS) symptoms via specific aspects of mindfulness.
    Naliboff BD, Smith SR, Serpa JG, Laird KT, Stains J, Connolly LS, Labus JS, Tillisch K.
    Neurogastroenterol Motil; 2020 Sep; 32(9):e13828. PubMed ID: 32266762
    [Abstract] [Full Text] [Related]

  • 7. A Study to Evaluate the Effectiveness of "Mindfulness-Based Stress Reduction Therapy(MBSRT)" in Reducing Symptom Severity and Improving Quality of Life in Patients Suffering From Irritable Bowel Syndrome.
    Ashraf MU, Akhouri D, Bhardwaj D, Siddiqui B.
    J Clin Gastroenterol; 2023 Oct 01; 57(9):945-950. PubMed ID: 36374952
    [Abstract] [Full Text] [Related]

  • 8. Comparing the Efficacy of Mindfulness-Based Stress Reduction Therapy with Emotion Regulation Treatment on Quality of Life and Symptoms of Irritable Bowel Syndrome.
    Ghandi F, Sadeghi A, Bakhtyari M, Imani S, Abdi S, Banihashem SS.
    Iran J Psychiatry; 2018 Jul 01; 13(3):175-183. PubMed ID: 30319700
    [Abstract] [Full Text] [Related]

  • 9. New psychological therapies for irritable bowel syndrome: mindfulness, acceptance and commitment therapy (ACT).
    Sebastián Sánchez B, Gil Roales-Nieto J, Ferreira NB, Gil Luciano B, Sebastián Domingo JJ.
    Rev Esp Enferm Dig; 2017 Sep 01; 109(9):648-657. PubMed ID: 28724306
    [Abstract] [Full Text] [Related]

  • 10. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
    Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin FP, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P.
    Gastroenterology; 2017 Aug 01; 153(2):448-459.e8. PubMed ID: 28483500
    [Abstract] [Full Text] [Related]

  • 11. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H, Guo Q, Wen Z, Tan S, Chen J, Lin L, Chen P, He J, Wen J, Chen Y.
    Microb Cell Fact; 2021 Dec 28; 20(1):233. PubMed ID: 34963452
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Comparison of WHOQOL-BREF with Disease Specific Heath Related Quality of Life Questionnaire in Irritable Bowel Syndrome.
    Jamali R, Biglari M.
    Acta Med Iran; 2015 Nov 28; 53(11):717-24. PubMed ID: 26786994
    [Abstract] [Full Text] [Related]

  • 14. Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial.
    Shahkaram H, Yaztappeh JS, Sadeghi A, Kianimoghadam AS, Soltanabadi S, Bakhtiari M, Arani AM.
    BMC Gastroenterol; 2024 Feb 06; 24(1):66. PubMed ID: 38321387
    [Abstract] [Full Text] [Related]

  • 15. Acceptance and commitment therapy versus mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: A randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life.
    Zhang Z, Leong Bin Abdullah MFI, Shari NI, Lu P.
    PLoS One; 2022 Feb 06; 17(5):e0267887. PubMed ID: 35536828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A pilot randomised trial comparing a mindfulness-based stress reduction course, a locally-developed stress reduction intervention and a waiting list control group in a real-life municipal health care setting.
    Juul L, Pallesen KJ, Bjerggaard M, Nielsen C, Fjorback LO.
    BMC Public Health; 2020 Mar 30; 20(1):409. PubMed ID: 32228533
    [Abstract] [Full Text] [Related]

  • 18. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
    Hoekman DR, Vlieger AM, Stokkers PC, Mahhmod N, Rietdijk S, de Boer NK, de Meij TG, Frankenhuis C, D'Haens GR, Benninga MA.
    J Crohns Colitis; 2021 Jul 05; 15(7):1106-1113. PubMed ID: 33245332
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.
    Piche T, Ducrotté P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, Hua M, Marine-Barjoan E, Dainese R, Hébuterne X.
    Neurogastroenterol Motil; 2010 Jun 05; 22(6):626-e174. PubMed ID: 20403099
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.